MedPath
FDA Approval

Ella

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
November 1, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Ulipristal(30 mg in 1 1)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ella

Product Details

NDC Product Code
73302-456
Application Number
NDA022474
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
November 1, 2023
Code: YF7V70N02BClass: ACTIBQuantity: 30 mg in 1 1
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath